TETRA Technologies, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Brady Murphy
- Full Time Employees
- 1,400
- Sector
- Energy
- Industry
- Oil & Gas Equipment & Services
- Address
- 10000 Energy Drive Spring TX United States of America 77380
- IPO Date
- Apr 3, 1990
- CIK
- 0000844965
- Website
- tetratec.com
- Similar Companies
- Business
- TETRA Technologies, Inc. (NYSE: TTI) provides specialized solutions to the energy and industrial sectors. The company manufactures and sells completion fluids, calcium chloride, brominated products; water management services, including onshore produced water recycling, lithium extraction from brines; and performance chemicals for oil and gas well completions, industrial applications. TETRA Technologies operates globally, with facilities in North America, Europe, and Latin America, targeting upstream energy producers, industrial manufacturers, and water management firms. Founded in 1981 and headquartered in The Woodlands, Texas, the company serves the oilfield services industry through its Water and Flowback Services, Completion Fluids and Products, and Performance Chemicals segments. It holds a leading position in clear brine fluids used in drilling and completions worldwide. In recent developments, TETRA Technologies expanded its lithium production capabilities with the commercial launch of its Phase 1A direct lithium extraction facility from produced water in Q1 2025; formed strategic alliances for sustainable water recycling technologies; and completed a $100 million funding round in late 2024 to support direct air capture and critical minerals initiatives. The company also acquired select assets from a competitor to bolster its bromine-based products portfolio in 2024. These moves reflect a strategic shift toward low-carbon energy transition services and diversification beyond traditional oilfield chemicals.
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS CONFERENCE CALL
Thiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript
Tvardi Therapeutics' TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
Tetra Technologies (TTI) Soars 6.6%: Is Further Upside Left in the Stock?
TETRA TECHNOLOGIES INTRODUCES TETRA NEPTUNE Z-LITE DEEPWATER COMPLETIONS FLUID
TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript
Thiogenesis Appoints Dr. Gilad Aharon to Its Board of Directors
Can Viavi's New TETRA Testing Upgrade Strengthen Its Growth Story?
VIAVI Launches TETRA MS Base Station Simulator Option for CX300 to Simplify and Speed Mission-Critical Radio Testing
Is TETRA Technologies a Buy After An Insider Bought 22,000 Shares?
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
TETRA TECHNOLOGIES, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK
Thiogenesis Upsizes Non-Brokered Private Placement of Common Shares
TETRA TECHNOLOGIES, INC. BOARD OF DIRECTORS APPROVES FINAL INVESTMENT DECISION FOR ARKANSAS BROMINE PRODUCTION FACILITY
Thiogenesis Announces Non-Brokered Private Placement
TETRA Technologies: Deep In The Oil Patch, A Critical Minerals Play Is Taking Shape
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update